Source link : https://www.newshealth.biz/health-news/fda-gives-nod-to-berdazimer-gel-for-molluscum-contagiosum/
On January 5, the Food and Drug Administration (FDA) approved berdazimer gel 10.3% for the treatment of molluscum contagiosum (MC) in adults and children aged 1 year or older. Approval of berdazimer, a topical nitric oxide–releasing agent, was based largely on a 12-week pivotal phase 3 trial known as B-SIMPLE4, in which 891 patients with […]
Author : News Health
Publish date : 2024-01-05 23:52:56
Copyright for syndicated content belongs to the linked Source.